ArticleInternational journal of clinical and experimental pathology2015

Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.

Hui Lyu et al.PubMed ↗Full text ↗

No numbers read from the abstract.